Tag Kara A. Thompson

Cardio-oncology

1 What is type I versus type II cardiotoxicity? Type I drugs cause irreversible cell loss and cumulative dose-related cardiotoxicity. Anthracyclines are type I drugs. Clinical manifestations of irreversible damage may not present for years owing to compensatory mechanisms. Stress…